Skip to main content
SpringerLink
Log in

Adrenal androgens and human breast cancer: A new appraisal

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

A clearer picture of the role of adrenal androgens in the etiology of breast cancer is beginning to emerge. Women who develop breast cancer in premenopausal years tend to have subnormal serum levels of adrenal androgens, while subjects who develop the disease in postmenopausal years have supranormal levels of these hormones. Androgens, by acting via the androgen receptor, oppose estrogen-stimulated cell growth in premenopausal years. In postmenopausal women, elevated adrenal androgen levels stimulate cell growth by the action of the unique adrenal androgen 5-androstene-3β,17β-diol, also termed hermaphrodiol, via its combination with the estrogen receptor in a hormone milieu lacking, or having low concentrations of, the classical estrogen 17β-estradiol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Beaulieu EE, Corpechot C, Dray F, Emilozzi R, Lebean M, Mauvais-Jarvis P, Robel P: An adrenal-secreted ‘androgen’: dehydroepiandrosterone sulfate, its metabolism and a tentative generalisation on the metabolism of other steroid conjugates in man. Recent Prog Hormone Res 21: 411–500, 1965

    Google Scholar 

  2. Allen BJ, Hayward JL, Merivale WMH: The exeretion of 17-kestosteroids in the urine of patients with carcinoma of the breast. Lancet 1: 496–497, 1957

    Google Scholar 

  3. Zumoff B: Hormone profiles and the epidemiology of breast cancer. In: Stoll BA (ed) Endocrine Relationships in Breast Cancer. Heinman, London, 1982, pp 3–47

    Google Scholar 

  4. Adams JB: Control of secretion and the function of C12-Δ5-steroids of the human adrenal gland. Mol Cell Endierinol 41: 1–17, 1985

    Google Scholar 

  5. Bulbrook RD, Hayward JL, Wang DY, Thomas BS, Clark GMG, Allen DS, Moore JW: Identification of women at high risk of breast cancer. Breast Cancer Res Treat 7(Suppl): 5–10, 1986

    Google Scholar 

  6. Bulbrook RD, Thomas BS: Hormones are ambiguous factors for breast cancer. Acta Oncologica 28: 841–847, 1989

    Google Scholar 

  7. Zumoff B, Levin J, Rosenfeld RS, Markham M, Strain GW, Fukushima DK: Abnormal 24-hr mean plasma concentration of dehydroepiandrosterone and dehydroepiandrosterone sulfate in women with primary operable breast cancer. Cancer Res 41: 3360–3363, 1981

    Google Scholar 

  8. Gordon GB, Bush TL, Helzlsouer KJ, Miller SR, Comstock GW: Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer. Cancer Res 50: 3859–3862, 1990

    Google Scholar 

  9. Helzlsouer KJ, Gordon GB, Alberg AJ, Bush TL, Comstock GW: Relationship of prediagnostic serum levels of dehydroplandrosterone and dehydroeplandrosterone sulfate to the risk of developing premenopausal breast cancer. Cancer Res 52: 1–4, 1992

    Google Scholar 

  10. Dorgan JF, Stanczyk F, Longcope C, Stephenson HE, Chang L, Miller R, Franz C, Falk RT, Kahle L: Relationship of serum DHEA, DHEAS and 5-androstene-3β,17β-diol to risk of breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prevention 6: 177–181, 1997

    Google Scholar 

  11. Bonney R, Scanlon MJ, Jones DL, Beranek PA, Reed MJ, James VHT: The interrelationship between plasma 5-ene adrenal androgens in normal women. J Steriod Biochem 20: 1353–1355, 1984

    Google Scholar 

  12. Huggins C, Jensen EV, Cleveland AS: Chemical structure of steroids in relation to promotion of growth of the vagina and uterus of the hypophysectomized rat. J Exp Med 100: 225–240, 1954

    Google Scholar 

  13. Adams J, Garcia M, Rochefort H: Estrogenic effects of physiological concentrations of 5-androstene-3β,17β-diol and its metabolism in MCF7 human breast cancer cells. Cancer Res 41: 4720–4726, 1981

    Google Scholar 

  14. Seymour-Munn K, Adams J: Estrogenic effects of 5-androstone-3β,17β-diol and its possible implication in the etiology of breast cancer. Endocrinology 112: 486–491, 1983

    Google Scholar 

  15. Poulin R, Labrie F: Stimulation of cell proliferation and estrogenic response by adrenal C19-Δ5-steroids in the ZR-75-1 human breast cancer cell line. Cancer Res 46: 4933–4937, 1986

    Google Scholar 

  16. Spinola PG, Marchetti B, Labrie F: Adrenal steroids stimulate growth and progesterone receptor levels in rat uterus and DMBA-induced mammary tumors. Breast Cancer Res Treat 81: 241–248, 1986

    Google Scholar 

  17. Adams JB, Martyn P, Lee F-T, Phillips NS, Smith DL: Metabolism of 17β-estradiol and the adrenal-derived estrogen 5-androstene-3β,17β-diol (Hermaphrodiol) in human mammary cell lines. Ann NY Acad Sci 595: 93–105, 1990

    Google Scholar 

  18. Rochefort H, Garcia M: Androgen on the estrogen receptor 1. Binding and in vivo nuclear translocation. Steroids 28: 549–560, 1976

    Google Scholar 

  19. Rochefort H, Garcia M: The estrogenic and antiestrogenic activities of androgens in female target tissues. Pharm Ther 23: 193–216, 1984

    Google Scholar 

  20. Poulin R, Baker D, Labrie F: Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res Treat 12: 213–225, 1988

    Google Scholar 

  21. Hackenberg R, Schulz K-D: Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen-and androgen-like steroids. J Steroid Biochem Mol Biol 56: 113–117, 1996

    Google Scholar 

  22. Bocuzzi G, Brignardello E, Di Monaco M, Gatto V, Leonardi L, Pizzini A, Gallo M: 5-En-androstene-3β,17β-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol. Br J Cancer 70: 1035–1039, 1994

    Google Scholar 

  23. Hayward JL, Greenwood FC, Glober G, Stemmerman G, Bulbrook RD, Wang DY, Kamaoka S: Endocrine status in normal British, Japanese and Hawaiian-Japanese women. Eur J Cancer 14: 1221–1228, 1978

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Biochemistry and Molecular Genetics, University of New South Wales, Sydney, NSW, Australia

    John B. Adams (Former visiting Professor)

Authors
  1. John B. Adams
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adams, J.B. Adrenal androgens and human breast cancer: A new appraisal. Breast Cancer Res Treat 51, 183–188 (1998). https://doi.org/10.1023/A:1006050720900

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006050720900

Search

Navigation